You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -13.6% | 72.5% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -147.1 | 406.3 |
PEG | 0.0 | 0.6 |
Price / Revenue | 63.5 | 2.2 |
Price / Book value | 57.0 |
Latest | Forecast | |
---|---|---|
Revenue | -4.7% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-12-31 | 11.08 | -5.71 | €-0.47 | 0.0 | 0.0 | n/a | n/a | 0.0% |
2017-12-31 | 12.75 | -3.49 | €-0.15 | -4.4 | 0.0 | n/a | n/a | 0.0% |
2018-12-31 | 13.72 | -2.08 | €-0.06 | -6.2 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 13.08 | -3.91 | €-0.08 | -1.9 | 0.0 | n/a | n/a | 0.0% |
Novacyt taps James McCarthy as new CFO Sharecast News | 05 Jan |
---|---|
Novacyt says its tests can detect new Covid strain, shares surge Sharecast News | 21 Dec |
Novacyt releases new tests for Covid-19, bird flu Sharecast News | 14 Dec |
Holdings in Company | 13-Jan-21 12:31 |
---|---|
Executive Management and Proposed Board Changes | 05-Jan-21 07:06 |
Liquidity Agreement and Total Voting Rights | 04-Jan-21 14:16 |
New COVID-19 variant | 21-Dec-20 07:06 |
Tests for new strains of COVID-19 and avian flu | 14-Dec-20 07:05 |